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Table 1. Putative Signs and Symptoms of CIRCI 
 
Clinical  
General Fever, asthenia  
Neurological Confusion 
Delirium 
Coma 
Cardiovascular Hypotension refractory to fluid resuscitation 
Decreased sensitivity to catecholamines 
High cardiac index 
Digestive Nausea 
Vomiting 
Intolerance to enteral nutrition 
Respiratory Persistent hypoxia  
Laboratory Hypoglycemia 
Hyponatremia 
Hyperkaliemia 
Metabolic acidosis 
Hypereosinophilia 
Imaging Hemorrhage or necrosis in hypothalamus, 
pituitary gland or adrenal gland 
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Table 2. Factors Determining Strong vs. Conditional Recommendation 
 
What Should be Considered Recommended Process 
High or moderate evidence 
(Is there high or moderate quality 
evidence?) 
The higher the quality of evidence, the more likely a strong 
recommendation 
Certainty about the balance of 
benefits vs. harms and burdens 
(Is there certainty?) 
The larger the difference between the desirable and undesirable 
consequences and the certainty around that difference, the more 
likely a strong recommendation. The smaller the net benefit and 
the lower the certainty for that benefit, the more likely a weak 
recommendation. 
Certainty in or similar values  
(Is there certainty or similarity?) 
The more certainty or similarity in values and preferences, the 
more likely a strong recommendation. 
Resource implications 
(Are resources worth expected 
benefits?) 
The lower the cost of an intervention compared to the alternative 
and other costs related to the decision—i.e., fewer resources 
consumed—the more likely a strong recommendation. 
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Table 3. Implications of the strength of recommendation 
 
 Strong Recommendation Conditional Recommendation 
For patients 
 
Most individuals in this situation 
would want the recommended 
course of action and only a small 
proportion would not. 
 
The majority of individuals in this 
situation would want the 
suggested course of action, but 
many would not. 
For clinicians 
 
Most individuals should receive 
the recommended course of 
action. Adherence to this 
recommendation according to the 
guideline could be used as a 
quality criterion or performance 
indicator. Formal decision aids 
are not likely to be needed to help 
individuals make decisions 
consistent with their values and 
preferences. 
 
Different choices are likely to be 
appropriate for different patients, 
and therapy should be tailored to 
the individual patient’s 
circumstances.  Those 
circumstances may include the 
patient or family’s values and 
preferences. 
 
For policy makers 
 
The recommendation can be 
adapted as policy in most 
situations including for the use as 
performance indicators. 
 
Policy making will require 
substantial debates and 
involvement of many 
stakeholders. Policies are also 
more likely to vary between 
regions. Performance indicators 
would have to focus on the fact 
that adequate deliberation about 
the management options has 
taken place. 
 
 
3 
 
